argenx SE (ARGX)
825.03
+6.40
(+0.78%)
USD |
NASDAQ |
Oct 09, 16:00
827.00
+1.97
(+0.24%)
After-Hours: 20:00
argenx Cash from Operations (Quarterly)
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2014 | 0.3306M |
| Date | Value |
|---|---|
| March 31, 2014 | -3.157M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -25.16M |
| Cellectis SA | -14.34M |
| Akari Therapeutics Plc | -3.112M |
| Forte Biosciences, Inc. | -22.70M |
| Halozyme Therapeutics, Inc. | 240.89M |
Cash from Operations (Quarterly) Related Metrics
| Free Cash Flow | 1.090B |
| Free Cash Flow Yield | 2.02% |